摘要
宫颈癌发病率在女性恶性肿瘤占第二位。宫颈癌的高危因素很多,如病毒感染、性行为、宫颈病变等因素。大量的研究已经证实人乳头瘤病毒(Human Papillomavirus HPV)感染是宫颈癌发生的必要条件。近年来,宫颈癌的筛查方法也取得了较大的进展,新发展的薄层液基细胞学(Liquid-based cytology test,LCT)、检测高危型HPVDNA的技术及宫颈癌筛查系统(TruScreen),显著提高了宫颈癌和癌前病变的灵敏性和特异性,从而降低了宫颈癌的发生率。
Cervical cancer remains the second leading cause of cancer related deaths among women across the world.It has more High-risk factors,for example,Viral infecton,sexual behavior,cervix pathological changes and so on.More research have been manifested that infection of Human papillomavirus（HPV） is necessary for the development of cervical cancer.Recently,the screen of cervical cancer have gained tremendous progress.Liquid-based cytology test（LCT）,detection of High-irisk HPV and TruScreen have elevated sensitivity and specificity of cervical cancer and precancer.Therefore,It can degraded incidence of cervical cancer.
出处
《现代生物医学进展》
CAS
2010年第1期190-193,共4页
Progress in Modern Biomedicine
